entertainment -WSS

entertainment

author：focus 2025-10-01 17:56:36 - browse：59

FogPharma CEO Mathai Mammen Venrock

SAN FRANCISCO — Six months into his tenure as CEO of cancer startup FogPharma, Mathai Mammen is taking the stage at the Westin St. Francis Tuesday for what he’s calling a “big unveil” of how he’s reshaping the biotech. And he’s prepared to go against the grain.

Perhaps the most important thing he’s telling investors at the J.P. Morgan Healthcare Conference is that he plans to eventually pursue a rare Series E round, rather than an IPO or seeking out acquisition offers.

FogPharma last raised money in November 2022, and will need more cash to bring its lead drug past its ongoing Phase 1/2 trial. Most other biotechs in this position are anxiously eyeing the capital markets, hoping that conditions improve and make an IPO more feasible. But Mammen doesn’t see the point, at this stage. “There’s no reason to be a public company. I don’t know why you’d want to be, really,” he told STAT ahead of FogPharma’s presentation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： STAT Readout Newsletter: Today's biggest biotech updates

WSS

Behind warning on Apellis’s eye drug lies a conflict of interest

Trump allegedly attempted to have surveillance video deleted: Special Counsel

Why health workers in Gaza are injured or die at high rates

Trump lawyers meet with special counsel in Jan. 6 case as potential indictment looms

Solve the antibiotic resistance crisis with preventive drugs

Solve the antibiotic resistance crisis with preventive drugs

focus

entertainment

hotspot

Jerome Adams on the need for new antivirals for Covid

STAT Summit: How a Chicago ER doctor tackles gun violence

United colonoscopy coverage change 'may cost lives,' doctors say

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

FDA approval of Sarepta Duchenne genetic therapy gives me hope

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

As demand for Covid shots wanes, Moderna seeks its next success

2023 STAT Wunderkinds: get to know the winners

Medical leaders decry Supreme Court decision on affirmative action

NIH confirmation hearing shows politicization of research

entertainment

The mammogram wars are not over

Ford recalls 870K F

Researchers explore possible ties between long Covid, menopause

Hospital price transparency does save money, advocate argues

Biden announces an advanced cancer research initiative

Biden to sign 'historic' executive order on how US military handles sexual assault cases

hotspot

hotspot

Wikipedia

focus